Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04523714 · ClinicalTrials.gov registry record · NA
Tailored Non-Pharmacotherapy Services for Chronic Pain
A NA study of Chronic Pain, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 2,333
- Enrollment target
- 4
- Study locations
NCT04523714: Completed NA study of Chronic Pain, sponsored by Kaiser Permanente.
NCT04523714 is a NA study of Chronic Pain that has completed, run by Kaiser Permanente. The registered enrollment target is 2,333 participants, above the 765-participant average among 301 other Chronic Pain trials with a reported enrollment target (205% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04523714, a NA study of Chronic Pain, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,333 participants
- Enrollment target
- 4
- Study locations
Study Summary
The RESOLVE study is a multicenter comparative effectiveness trial of two cognitive behavioral therapy-based chronic pain (CBT-CP) treatments delivered via telehealth modalities: 1) online program and 2) live, health coach-led, virtual sessions (telephone and/or video conference).
Primary Outcome
Minimal clinically important difference (MCID) in pain severity is defined as a 30% or greater improvement in pain severity score. \[Pain severity score assessed via modified 11-item version of the Brief Pain Inventory - Short Form (BPI-SF) from baseline (consistent with IMMPACT guidelines). The BPI-SF range= 0 to 10; higher score = worse pain severity.\] MCID outcome is binary; reported as the adjusted percentage of participants with MCID (\> or =30% improvement) in pain severity.
Conditions Studied
Interventions
- BEHAVIORAL Online CBT-CP based program
- BEHAVIORAL Virtual health coach-led CBT-CP based program
Study Locations (4)
Georgia
- Kaiser Permanente Georgia, Center for Research and Evaluation - Atlanta
Minnesota
- Essentia Institute of Rural Health - Duluth
Oregon
- Kaiser Permanente Northwest Center for Health Research - Portland
Washington
- Kaiser Permanente Washington Health Research Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,333 participants |
| Start Date | 2021-01-14 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What the finished NCT04523714 record still lists
NCT04523714 is an interventional study that assigns participants to a tested intervention. Its 2,333 participants enrollment target places it among the larger protocols in the corpus, above the 765-participant average among 301 other Chronic Pain trials with a reported enrollment target (205% higher).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Online CBT-CP based program is the first listed.
NCT04523714 reports a single indexed study location in Georgia, Minnesota, Oregon.
Frequently Asked Questions
What is clinical trial NCT04523714 about?
NCT04523714 is a clinical study titled "Tailored Non-Pharmacotherapy Services for Chronic Pain". The RESOLVE study is a multicenter comparative effectiveness trial of two cognitive behavioral therapy-based chronic pain (CBT-CP) treatments delivered via telehealth modalities: 1) online program and 2) live, health coach-led, virtual sessions (telephone and/or video conference).
What is the current status of trial NCT04523714?
This trial is currently completed. It is a NA study. The enrollment target is 2,333 participants. The study started on 2021-01-14. Estimated completion is 2025-08-31.
What conditions does trial NCT04523714 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT04523714?
The interventions under investigation include: Online CBT-CP based program (BEHAVIORAL), Virtual health coach-led CBT-CP based program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04523714?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04523714 being conducted?
This trial has 4 study locations across Georgia, Minnesota, Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04523714's enrollment target sits among peer trials
2,333 7th of 301 higher than 295 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06679140 · 2,330 participants · Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- NCT03099850 · 2,345 participants
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
- NCT06824194 · 2,320 participants · Phase 3
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI